|
|
||||||||
J Thorac Cardiovasc Surg 2003;125:740-741
© 2003 The American Association for Thoracic Surgery
Letters to the Editor |
Division of Thoracic Surgery, Cardiac and Thoracic Departmenta, Division of Neurology, Department of Neurosciencesb, University of Pisa, Pisa, Italy
| The first 20% of the full text of this article appears below. |
To the Editor:
We read with interest the recent article by Roberts and associates
1 on thymectomy in the treatment of ocular myasthenia gravis (OMG). It represents an important step in the debate concerning this issue and in the consideration of OMG as part of a broad-spectrum disease and not as a distinct disease.
What we know from the literature is that the disease will progress in about 50% of patients with initial OMG.
2 On the other hand, thymectomy is considered a mainstay therapy for generalized myasthenia gravis (GMG), and the best outcome is expected in patients operated on early after the
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |